People wait to receive the vaccine for COVID-19 at a vaccination center in Mumbai, India, Thursday, Aug. 19, 2021. (AP Photo/Rafiq Maqbool)
Coronavirus India Highlights: An expert panel, set up by an institute under the Ministry of Home Affairs (MHA), has predicted a third wave of Covid-19 hitting the country anytime between September and October and suggested significantly ramping up vaccination pace, reported PTI. The committee of experts, constituted by the National Institute of Disaster Management (NIDM), also said that children will have a similar risk as adults since paediatric facilities, doctors and equipment like ventilators, ambulances, etc. are nowhere close to what may be required in case a large number of children become infected.
The report, which has been submitted to the Prime Minister’s Office (PMO), observed that only around 7.6 percent (10.4 cr) people are fully vaccinated in India and if the current vaccination rate is not increased, India can witness six lakh cases per day in the next wave.
Meanwhile, India recorded 25,072 new cases of Covid-19 in the 24 hours ending 8 am Monday, lowest in 160 days. The active cases stood at 3.33 lakh and accounted for 1.03 per cent of the total cases. Active cases were at their lowest in 155 days while the country’s recovery rate increased to 97.63 per cent. With 389 new fatalities, the death toll is now over 4,34 lakh.
India reports 25,072 new cases, 389 deaths; Shree Jagannath Temple reopens from today.
People line up to get inoculated against Covid-19 outside a vaccination centre in Mumbai. (AP Photo)
A day after Haryana government informed the Vidhan Sabha that no deaths due to a lack of oxygen have been reported in state during the Covid pandemic, former Chief Minister Bhupinder Singh Hooda Saturday accused the ruling BJP-JJP alliance of misleading the public.
Showing copies of news reports related to the deaths during the second wave of Corona, Hooda said, “The government has given wrong information in the Assembly”.
A K Khanna, 65, a former top official at a pharmaceutical firm and presently chairman of a healthcare company, was among the first five participants in the clinical trials of Covishield vaccine conducted by the Serum Institute of India and the Indian Council of Medical Research (ICMR) a year ago. Along with his wife and daughter, Khanna received his vaccine doses in August last year.
A year later, he has to furnish RT-PCR test results every time he has to board a flight, because, unlike other vaccinated people, he still doesn’t have a government software-generated certificate. The one that the trial site had provided has often been dubbed “fake”.
People who have had severe or long-lasting cases of Covid-19 are more likely to have high levels of an important antibody needed to fight against future infection, according to a new study from Rutgers University published in The Journal of Infectious Diseases.
The published paper, ‘Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study’, was part of the larger Rutgers Corona Cohort study, which followed 548 healthcare workers and 283 others from the start of the pandemic.